PROK

PROKIDNEY CORP.

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1850270Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$<0.01B

Net Income FY2025

$(0.07B)

EPS (Basic, as reported)

—

Net Margin FY2025

-7725.2%

ROE FY2025

6.8%

Total Equity

$(1.01B)

Shares Out

—

Business description

PROKIDNEY CORP. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 0 → 1

Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025

Revenue——0001

Research & development(21)(46)(82)(107)(128)(114)

General & administrative(6)(9)(71)(45)(56)(52)

Total operating expenses(27)(55)(153)(152)(184)(166)

Operating income(27)(55)(153)(152)(184)(165)

Interest expense000000

Pre-tax income(27)(55)(147)(129)(164)(151)

Income tax expense00(1)(6)(1)0

Net income(27)(55)(148)(35)(61)(69)

EPS — basic——($0.23)———

EPS — diluted——($0.23)———

Shares outstanding — basic (M)——62———

Shares outstanding — diluted (M)——62———

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.